Insider trade

CEO sold ~$1.52M of EW shares in the open market

Traded Feb 12, 2026 · Filed Feb 13, 2026

Edwards LifesciencesEW

~$1.52M
Reported value · 20K sh @ $76.6133: 84K
Holds after · shares reported: +11.4%
stock since the trade · S&P 500 +12.1%, $76.44 → $85.19 on Oct 1

Why it stands out

The boss of Edwards Lifesciences sold $1.52M of Edwards Lifesciences shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 12, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 13, 2026

CEO$1M+

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,524,451

Shares × reported transaction price

Timing vs results

2 days after results of Feb 10, 2026, 70 days before results of Apr 23, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $76.44 on Feb 12, 2026, 14% above its 52-week low and 12% below its high, after an 11% drop over the previous 30 trading days

52-week range $67.07 (Apr 8, 2025) to $86.94 (Dec 29, 2025), 47% of the way up, from 251 adjusted closes. 30 trading days earlier: $86.20 on Dec 30, 2025. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on Oct 14, 2024 in the U.S. District Court, C.D. California. A filing is an allegation, not a finding.

Dhimant Patel v. Edwards Lifesciences Corporation, docket 8:24-cv-02221, via CourtListener (court records). Nature of suit 850, company named as first defendant

After it was reported

After	Stock	S&P 500	Difference
7 days	+5.0%	+0.7%	+4.4%
30 days	+5.1%	-3.4%	+8.5%
90 days	+5.0%	+8.2%	-3.1%
180 days	+15.8%	+13.2%	+2.6%

Past results only. Not a forecast.

Source receipt

Record ID: 0001225208-26-001893
Filed / recorded: Feb 13, 2026, 10:37 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: Edwards Lifesciences Corp
Issuer CIK: 1099800
Ticker: EW
Reporting person: Bernard J Zovighian
Relationship: Director, Officer
Officer title: CEO
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Feb 12, 2026
Transaction code: S
Shares / units: 19,898
Price per share: $76.6133
Acquired / disposed: Disposed (D)
Shares owned after: 83,896
Ownership form: Direct
Amendment: No

Footnotes from the filing

This transaction was executed in multiple trades at prices ranging from $76.080 to $77.075 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.